Ann Oncol

1. TARPGAARD LS, Andersen PV, Ogaard N, Demuth C, et al
   Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer.
   Ann Oncol. 2021;32:805-806.
   

   >> Share

   
   

   
   Ann Surg

2. BALVARDI S, Pecorelli N, Castelino T, Niculiseanu P, et al
   Impact of Facilitation of Early Mobilization on Postoperative Pulmonary Outcomes After Colorectal Surgery: A Randomized Controlled Trial.
   Ann Surg. 2021;273:868-875.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. NAKANISHI R, Oki E, Hasuda H, Sano E, et al
   ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
   Ann Surg Oncol. 2021;28:2986-2987.
   

   >> Share

   
   
4. HEWITT DB, Pawlik TM, Cloyd JM
   Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases.
   Ann Surg Oncol. 2021;28:2931-2933.
   

   >> Share

   
   
5. ROSSI AJ, Khan TM, Rehman SU, Nash GM, et al
   Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS).
   Ann Surg Oncol. 2021 May 25. pii: 10.1245/s10434-021-10110.
   

   >> Share

   
   

   
   BMC Cancer

6. TIAN P, Zhu Y, Zhang C, Guo X, et al
   Retraction Note: Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
   BMC Cancer. 2021;21:594.
   

   >> Share

   
   
7. HAMMAD A, Zheng ZH, Namani A, Elshaer M, et al
   Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
   BMC Cancer. 2021;21:607.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. SIVANDZADEH GR, Ejtehadi F, Shoaee S, Aminlari L, et al
   Endoscopic mucosal resection: still a reliable therapeutic option for gastrointestinal neuroendocrine tumors.
   BMC Gastroenterol. 2021;21:238.
   

   >> Share

   
   

   
   Cancer Res

9. MILLER SA, Policastro RA, Sriramkumar S, Lai T, et al
   LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF mutant colorectal cancer.
   Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-3562.
   

   >> Share

   
   

   
   Eur J Cancer

10. SAESEN R, Lacombe D, Huys I
    Design, organisation and impact of treatment optimisation studies in breast, lung and colorectal cancer: The experience of the European Organisation for Research and Treatment of Cancer.
    Eur J Cancer. 2021;151:221-232.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

11. ROJAS A, Gachabayov M, Tewari V, Veillette G, et al
    Clostridium septicum liver abscess following colonoscopic stenting of transverse colon cancer.
    Eur J Gastroenterol Hepatol. 2021;33:1032-1033.
    

    >> Share

    
    

    
    Eur J Surg Oncol

12. BASTIAENEN VP, Aalbers AGJ, Arjona-Sanchez A, Bellato V, et al
    Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Eur J Surg Oncol. 2021 May 15. pii: S0748-7983(21)00485.
    

    >> Share

    
    
13. CHESNEY TR, Metz JJ, Nadler A, Quereshy FA, et al
    Long-term outcomes of resection for locoregional recurrence of colon cancer: A retrospective descriptive cohort study.
    Eur J Surg Oncol. 2021 May 19. pii: S0748-7983(21)00479.
    

    >> Share

    
    

    
    Int J Colorectal Dis

14. ICHIKAWA Y, Takahashi H, Fujii M, Hata T, et al
    Radical lymphadenectomy of a para-aorta lymph node metastasis in colorectal cancer prolongs relapse-free survival.
    Int J Colorectal Dis. 2021 May 27. pii: 10.1007/s00384-021-03961.
    

    >> Share

    
    

    
    J Surg Oncol

15. HONG HJ, Zhao X, Yu CR, Sun J, et al
    Comparative study of oncologic efficacy of cephalomedial to lateral dissection versus medial to lateral dissection in laparoscopic total mesorectal excision for rectal cancer: An RCT study.
    J Surg Oncol. 2021;123 Suppl 1:S65-S75.
    

    >> Share

    
    
16. AN YB, Yao HW, Yang XH, Zhang X, et al
    Verification of data in a nationwide transanal total mesorectal excision registry in China.
    J Surg Oncol. 2021;123 Suppl 1:S43-S51.
    

    >> Share

    
    
17. XIAO Y, Lin C, Lu JY, Xu L, et al
    Short-term outcomes of pure transvaginal laparoscopic right colectomy: A novel surgery approach based on an Idea, Development, Exploration, Assessment, Long-term framework stage IIa study.
    J Surg Oncol. 2021;123 Suppl 1:S36-S42.
    

    >> Share

    
    
18. ZHAO X, Ma J, Fu Z, Hong H, et al
    Prognostic value of apical lymph node metastasis at the inferior mesenteric artery in sigmoid and rectal cancer patients who undergo laparoscopic surgery.
    J Surg Oncol. 2021;123 Suppl 1:S88-S94.
    

    >> Share

    
    
19. JIANG TY, Ma JJ, Zheng MH
    Controversies and consensus in transanal total mesorectal excision (taTME): Is it a valid choice for rectal cancer?
    J Surg Oncol. 2021;123 Suppl 1:S59-S64.
    

    >> Share

    
    
20. FENG W, Zong Y, Zhao J, Li W, et al
    High versus low ligation of the inferior mesenteric artery during laparoscopic rectal cancer surgery: A prospective study of surgical and oncological outcomes.
    J Surg Oncol. 2021;123 Suppl 1:S76-S80.
    

    >> Share

    
    
21. LI R, Shen K, Wang Z, Xie Z, et al
    Short-term outcomes of medium-low rectal cancer treated by taTME and experience of 22 cases.
    J Surg Oncol. 2021;123 Suppl 1:S52-S58.
    

    >> Share

    
    
22. PATEL S, Sukumar V, Kazi M, Saklani A, et al
    Safety and feasibility of sphincter preservation surgery in low lying rectal cancers.
    J Surg Oncol. 2021;123:1651-1652.
    

    >> Share

    
    
23. JIANG TY, Zang L, Dong F, Feng B, et al
    Effect of different reinforcement methods on anastomotic leakage prevention after laparoscopic double anastomosis.
    J Surg Oncol. 2021;123 Suppl 1:S81-S87.
    

    >> Share

    
    

    
    Lancet Oncol

24. CARDOSO R, Guo F, Heisser T, Hackl M, et al
    Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.
    Lancet Oncol. 2021 May 25. pii: S1470-2045(21)00199.
    

    >> Share

    
    
25. GOGENUR I, Qvortrup C
    Colorectal cancer screening in Europe: what are the next steps?
    Lancet Oncol. 2021 May 25. pii: S1470-2045(21)00276.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share